Abstract:7031 Background: Telomeres play a key role in maintaining chromosome stability. Shorter telomere length has been demonstrated to be a risk factor for lung cancer. A significant number of patients with non-small cell lung cancer (NSCLC) will develop recurrence after curative resection. To potentially identify this subgroup of patients, we hypothesized that telomere length in peripheral blood would have significant predictive value for risk of recurrence. Methods: Relative telomere length (RTL) of peripheral leukocytes was measured by real-time PCR in 403 patients with early stage NSCLC who underwent curative resection at M. D. Anderson Cancer Center between 1991 and 2007. The risk of recurrence was estimated as hazard ratios (HRs) and 95% confidence intervals (CIs) using a multivariable Cox proportional hazard regression model. Results: Median duration of follow- up was 29.9 months (0.1-158.8 months) and 87 patients (21.6%) had developed recurrence at time of analysis. 60 patients (14.9%) received chemotherapy (mostly adjuvant) with surgery. Our results show that the recurrence group demonstrated significantly longer mean RTL compared to the nonrecurrence group (1.19 vs. 1.07, p=0.003). Furthermore, the risk of recurrence increased as telomere length increased (p-trend=0.004). When 75th percentile value of RTL was used to dichotomize telomere length, patients with long telomeres were at higher risk of recurrence (HR=1.72; 95% CI, 1.08-2.72, p =0.021). This increased risk was most pronounced in adenocarcinoma subgroup (HR=2.28; 95% CI, 1.31-3.98, p = 0.004). When categorized into surgery only or surgery and chemotherapy group, longer telomeres increased risk of recurrence in the surgery only group (HR=1.81; 95% CI, 1.06-3.11, p=0.031). However, this association was not evident in the chemotherapy group (HR=1.13; 95% CI, 0.34-3.70, p=0.85). Conclusions: This is the first study to suggest that long telomere length is associated with increased risk of recurrence in early stage NSCLC after curative resection. Chemotherapy may be considered to overcome this increased risk. This study is supported by NCI CA 111646, CA 55769, and CA 70907. No significant financial relationships to disclose.

Long Telomeres in Peripheral Blood Leukocytes Are Associated with an Increased Risk of Soft Tissue Sarcoma.

Association Between Leukocyte Telomere Length and Glioma Risk: a Case-Control Study.

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.

Reduced Mitochondrial Dna Copy Number in Peripheral Blood Leukocytes Increases the Risk of Soft Tissue Sarcoma

Leukocyte Telomere Length and Risk of Secondary Primary Tumors in Long-Term Breast Cancer Survivors

Telomere dysfunction: a potential cancer predisposition factor.

The Association of Telomere Length and Cancer: a Meta-analysis

Shorter Telomere Length is Associated with Increased Breast Cancer Risk in a Chinese Han Population: A Case-Control Analysis.

Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians.

Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis

Leukocyte Telomere Length Associated with Glioma Risk and Survival

No Association Between Telomere Length in Peripheral Blood Leukocytes and the Risk of Nonmelanoma Skin Cancer

Combined Effects of Leukocyte Telomere Length, P53 Polymorphism and Human Papillomavirus Infection on Esophageal Squamous Cell Carcinoma in a Han Chinese Population.

Telomere Dysfunction in Peripheral Lymphocytes As a Potential Predisposition Factor for Renal Cancer

Association of Leukocyte Telomere Length with Breast Cancer Risk: Nested Case-Control Findings from the Shanghai Women's Health Study.

Use of Telomere Length in Peripheral Leukocytes to Predict Risk of Recurrence in Patients with Early-Stage Non-Small Cell Lung Cancer after Curative Resection.

Long-telomeropathy is associated with tumor predisposition syndrome

Genetically Predicted Longer Telomere Length is Associated with Increased Risk of B-cell Lymphoma Subtypes.

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Long Telomere Length Predicts Poor Clinical Outcome in Esophageal Cancer Patients.

Telomere Length and Recurrence Risk after Curative Resection in Women with Adenocarcinoma of the Lung: A Prospective Cohort Study.